Cognition Therapeutics In... (CGTX)
NASDAQ: CGTX
· Real-Time Price · USD
1.54
-0.12 (-7.23%)
At close: Aug 15, 2025, 3:59 PM
1.57
1.62%
After-hours: Aug 15, 2025, 07:56 PM EDT
Cognition Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 250K | 250K | 250K | 372K | 372K | 372K | 372K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 247K | 253K | 266K | 261K | 256K | 250K | 252K | 246K | 241K | 239K | 235K | 198K | 161K | 126K | 93K | 70K | 47K | 23K |
Gross Profit | -247K | -253K | -266K | 111K | 116K | 122K | 120K | -246K | -241K | -239K | -235K | -198K | -161K | -126K | -93K | -70K | -47K | -23K |
Operating Income | -52.94M | -53.64M | -53.97M | -58.43M | -58.71M | -55.85M | -50.72M | -44.84M | -42.72M | -43.11M | -43.55M | -46.06M | -38.66M | -32.43M | -28.6M | -20.91M | -20.15M | -18.1M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -32.99M | -33.3M | -33.97M | -34.27M | -31.08M | -28.77M | -25.79M | -22.83M | -22.7M | -23.86M | -21.4M | -23.55M | -20.04M | -15.65M | -11.72M | -6.25M | -4.93M | -5.11M |
Net Income | -32.99M | -33.3M | -33.97M | -34.27M | -31.08M | -28.77M | -23M | -3.88M | 2.24M | 1.21M | 757K | -17.55M | -20.04M | -15.78M | -11.72M | -6.25M | -4.93M | -5.11M |
Selling & General & Admin | 11.13M | 11.73M | 12.23M | 13.19M | 13.19M | 13.41M | 13.46M | 12.8M | 14.08M | 13.88M | 13.23M | 16.6M | 13.79M | 11.77M | 10.03M | 4.62M | 4.14M | 4.23M |
Research & Development | 41.81M | 41.91M | 41.68M | 45.12M | 45.4M | 42.32M | 37.2M | 32.04M | 28.64M | 29.24M | 30.32M | 29.46M | 24.86M | 20.66M | 18.57M | 16.29M | 16.01M | 13.87M |
Other Expenses | -71K | -71K | -71K | n/a | n/a | 172K | -3.25M | -7.24M | -13.18M | -13.4M | -15.87M | -12.5M | -7.47M | -8.37M | -2.32M | -1.59M | -572K | 485K |
Operating Expenses | 52.87M | 53.57M | 53.84M | 58.31M | 58.59M | 48.8M | 40.31M | 30.5M | 22.44M | 23.37M | 21.33M | 22.75M | 18.26M | 13.77M | 11.15M | 5.83M | 4.91M | 4.83M |
Interest Expense | 6K | 10K | 25K | 29K | 28K | 27K | 27K | 28K | 28K | 29K | 28K | 18K | 16K | 366K | 894K | 1.42M | 1.93M | 2.01M |
Selling & Marketing Expenses | n/a | n/a | -58K | -124K | -124K | -124K | -66K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 52.94M | 53.64M | 53.97M | 58.43M | 58.71M | 48.93M | 40.37M | 30.5M | 22.44M | 23.37M | 21.33M | 22.75M | 18.26M | 13.77M | 11.15M | 5.83M | 4.91M | 4.83M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -2.79M | -18.95M | -24.95M | -25.07M | -22.15M | -6M | n/a | 125K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 63.69M | 61.83M | 46.43M | 40.42M | 40.06M | 33.74M | 30.78M | 30.37M | 29.61M | 29.09M | 28.99M | 23.02M | 22.6M | 22.43M | 20.95M | 20.95M | 20.95M | 21.37M |
Shares Outstanding (Diluted) | 63.69M | 61.83M | 46.43M | 40.42M | 40.06M | 33.74M | 30.78M | 30.37M | 29.61M | 29.09M | 28.99M | 23.02M | 22.6M | 22.43M | 20.95M | 20.95M | 20.95M | 21.37M |
EPS (Basic) | -0.67 | -0.74 | -0.87 | -0.96 | -0.93 | -0.91 | -0.76 | -0.12 | 0.07 | -0.02 | -0.07 | -0.8 | -0.92 | -0.74 | -0.56 | -0.3 | -0.23 | -0.24 |
EPS (Diluted) | -0.67 | -0.74 | -0.87 | -0.96 | -0.93 | -0.91 | -0.76 | -0.12 | 0.07 | -0.02 | -0.07 | -0.8 | -0.92 | -0.74 | -0.56 | -0.3 | -0.23 | -0.24 |
EBITDA | -45.38M | -38.37M | -33.68M | -33.98M | -30.8M | -28.49M | -25.51M | -22.55M | -22.44M | -23.59M | -21.13M | -23.34M | -19.86M | -15.16M | -10.73M | -7.51M | -5.68M | -5.78M |
EBIT | -32.98M | -33.28M | -33.95M | -34.24M | -31.05M | -28.74M | -25.76M | -22.8M | -22.68M | -23.83M | -21.37M | -23.54M | -20.02M | -15.29M | -10.82M | -4.82M | -3M | -3.1M |
Depreciation & Amortization | 186K | 253K | 266K | 261K | 256K | 250K | 252K | 246K | 241K | 239K | 235K | 198K | 161K | 126K | 93K | 94K | 95K | 96K |